Table 5. Proportion of medication adherence among patients attending HIV clinics in two cities as measured by laboratory-confirmed HIV viral suppression (< 200 copies/ml) at 183 days or 6 months, August 1, 2015-March 31, 2017, by subgroups of patient characteristics.
| Atlanta | Huntsville | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Comparison | Intervention | Percentage Point Change | p-value | Comparison | Intervention | Percentage Point Change | p-value | ||
| Characteristic | Category | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | ||
| Patients, N | — | 1327 | 1302 | — | — | 653 | 721 | — | — |
| Clinic location | — | 41.1 (37.8, 44.7) | 58.7 (55.6, 61.8) | 17.5 (12.9, 22.2) | <0.01 | 77.7 (74.2, 81.1) | 69.1 (65.4, 72.8) | -8.6 (-13.7, -3.5) | <0.01 |
| Sex/gender | Male | 40.7 (36.7, 44.9) | 57.5 (54.0, 61.1) | 16.8 (11.4, 22.2) | <0.01 | 75.7 (71.5, 79.8) | 72.4 (68.1, 76.5) | -3.4 (-9.3, 2.5) | 0.26 |
| Female | 42.6 (36.0, 49.8) | 61.2 (54.6, 67.8) | 18.6 (9.0, 28.1) | <0.01 | 82.9 (76.3, 88.6) | 59.5 (51.5, 67.6) | -23.5 (-33.7, -13.2) | <0.01 | |
| Transgender | 33.3 (12.2, 71.8) | 70.4 (48.6, 89.2) | 37.1 (-0.6, 74.8) | 0.05 | 100 (100, 100) | 63.6 (37.3, 88.8) | -36.4 (-64.8, -7.9) | 0.01 | |
| Race/ ethnicity | Black, non-Hisp | 41.8 (38.3, 45.6) | 58.3 (55.1, 61.6) | 16.5 (11.6, 21.4) | <0.01 | 74.3 (68.9, 79.4) | 65.7 (60.2, 71.2) | -8.6 (-16.3, -0.9) | 0.03 |
| Hispanic | 29.4 (13.4, 56.9) | 76.0 (56.7, 91.3) | 46.6 (18.3, 75.0) | <0.01 | 87.7 (74.9, 95.8) | 69.2 (54.6, 82.7) | -18.5 (-36.5, -0.5) | 0.04 | |
| White, non-Hisp | 30.4 (18.5, 47.3) | 53.6 (39.5, 69.1) | 23.3 (2.4, 44.2) | 0.03 | 79.7 (74.5, 84.5) | 73.5 (68.0, 78.7) | -6.2 (-13.6, 1.1) | 0.10 | |
| Other | 61.5 (29.8, 92.4) | 66.9 (45.9, 86.3) | 5.4 (-37.0, 47.7) | 0.80 | 80.0 (52.5, 96.9) | 49.5 (24.3, 81.3) | -30.5 (-70.2, 9.2) | 0.13 | |
| Wht+Hisp+Oth | 33.6 (23.7, 46.2) | 62.2 (51.7, 72.6) | 28.6 (13.1, 44.0) | <0.01 | 80.7 (76.1, 85.0) | 72.2 (67.1, 77.0) | -8.6 (-15.3, -1.8) | 0.01 | |
| Age | 18–24 years | 25.0 (3.9, 87.2) | 50.9 (39.1, 67.6) | 25.9 (-19.5, 71.3) | 0.26 | 80.8 (64.3, 92.8) | 75.1 (61.5, 86.8) | -5.7 (-25.4, 14.1) | 0.58 |
| 25–34 years | 46.2 (40.0, 52.8) | 52.1 (46.8, 57.6) | 5.9 (-2.5, 14.3) | 0.17 | 75.5 (68.8, 81.8) | 69.3 (62.6, 75.9) | -6.2 (-15.5, 3.2) | 0.20 | |
| 35–87 years | 39.0 (35.0, 43.3) | 62.7 (58.9, 66.5) | 23.7 (18.1, 29.4) | <0.01 | 78.4 (74.1, 82.5) | 68.3 (63.5, 73.0) | -10.2 (-16.5, -3.8) | <0.01 | |
| HIV risk | MSM | 38.2 (33.0, 44.0) | 61.9 (56.9, 66.9) | 23.7 (16.3, 31.1) | <0.01 | 81.9 (76.3, 86.9) | 65.1 (58.7, 71.4) | -16.8 (-25.1, -8.5) | <0.01 |
| Heterosexual | 43.5 (38.9, 48.5) | 56.7 (52.6, 60.9) | 13.2 (6.9, 19.6) | <0.01 | 75.9 (71.1, 80.4) | 71.5 (66.6, 76.2) | -4.4 (-11.1, 2.3) | 0.20 | |
| Other | 39.9 (28.2, 54.2) | 56.8 (44.4, 69.8) | 16.9 (-1.5, 35.3) | 0.07 | 70.6 (55.6, 84.2) | 70.2 (54.3, 84.6) | -0.4 (-22.0, 21.1) | 0.97 | |
| Time since HIV diagnosis* |
< 1 year | 39.5 (27.7, 54.1) | 51.3 (38.9, 65.0) | 11.8 (-7.0, 30.6) | 0.22 | 80.8 (65.2, 92.4) | 77.1 (63.0, 88.7) | -3.8 (-23.1, 15.6) | 0.70 |
| 1–5 years | 40.9 (35.5, 46.7) | 59.4 (54.6, 64.3) | 18.5 (11.1, 26.0) | <0.01 | 78.1 (71.8, 83.8) | 74.4 (67.9, 80.4) | -3.7 (-12.4, 5.0) | 0.40 | |
| 6–10 years | 38.7 (32.4, 45.8) | 51.2 (45.3, 57.4) | 12.5 (3.4, 21.5) | 0.01 | 77.9 (71.0, 84.1) | 66.1 (58.7, 73.4) | -11.8 (-21.8, -1.9) | 0.02 | |
| > 10 years | 44.0 (37.6, 51.0) | 66.6 (60.8, 72.3) | 22.6 (13.8, 31.5) | <0.01 | 76.5 (70.3, 82.2) | 64.3 (57.9, 70.8) | -12.1 (-20.9, -3.3) | 0.01 | |
Notes. Other race/ethnicity includes American Indian/Alaska Native, Asian, Pacific Islander/Native Hawaiian, multiple races, and not specified. Other HIV risk includes injection drug use, MSM who inject drugs, hemophilia, transfusion, perinatal, and not specified. Hisp = Hispanic. MSM = men who have sex with men. N = total patients in study period. Oth = Other. Wht = White.
*Time since HIV diagnosis was assessed at index clinic visit date.